Work

Does Mechanical Circulatory Support–Assisted Percutaneous Coronary Intervention Improve Left Ventricular Function?

Year: 2022

Type: editorial

Abstract: Ischemic cardiomyopathy (ICM) remains a leading cause of mortality and morbidity despite advances in guideline-directed medical therapy (GDMT) and defibrillator and/or cardiac resynchronization therapy (CRT) as well as other advanced therapies. Concerningly, a recent report demonstrated that <40% of patients with systolic dysfunction and new-onset heart failure will even undergo coronary artery disease (CAD) testing.1 In addition to administration of GDMT, for patients with ICM with multivessel or left main CAD and left ventricular ejection fraction (LVEF) of ≤35%, evaluation for coronary artery bypass graft (CABG) is a class I recommendation based on the Surgical Treatment for Ischemic Heart Failure Extension Study (STICHES)2; however, for some patients, CABG may be prohibitively high risk or may not be an acceptable option.

Source: Journal of the Society for Cardiovascular Angiography & Interventions

DOI: 10.1016/j.jscai.2022.100387

Authors: Akl C. Fahed, Farouc A. Jaffer

Institutions: Broad Institute, Harvard University, Massachusetts General Hospital, Massachusetts Institute of Technology

Language: English

Topic: Mechanical Circulatory Support Devices

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,400

OpenAlex ID: W4291127752

Cites: 12

Cited by:

Related to: 10